Fierce Pharma

APRIL 18, 2023

Big Pharmas finally strike with GSK, Merck acquisitions, signaling accelerating pace of M&A aarmstrong Tue, 04/18/2023 - 09:47

Pharma 245

Pharma 245

MedCity News

APRIL 18, 2023

Glen Tullman — CEO of care navigation company Transcarent, as well as former CEO of Allscripts and Livongo — discussed what he thinks the future of healthcare will look like during the HIMSS conference in Chicago. He laid out five predictions, including an increased focus on consumer expectations and more investment in AI.

Healthcare 125

Healthcare Healthcare 125

Fierce Pharma

APRIL 18, 2023

AbbVie's Qulipta gains edge on Pfizer's Nurtec with FDA approval to prevent chronic migraines zbecker Tue, 04/18/2023 - 11:09

FDA 235

FDA 235

Medgadget

APRIL 18, 2023

Researchers at MIT have developed lipid nanoparticles that are highly efficient at delivering mRNA therapies to lung cells. Getting therapeutic agents into the lungs can be challenging, but there are a variety of medical challenges that could be addressed by efficiently targeting lung cells with nanoparticle technologies. These latest particles are highly efficient at delivering mRNA which can then encode therapeutically useful proteins in the lungs.

Engineering 122

Engineering Medical Patients Medicine 122

Advertisement

Distribution

Fierce Pharma

APRIL 18, 2023

Double whammy: Supreme Court slaps down separate bids from Novartis, Sanofi esagonowsky Tue, 04/18/2023 - 08:25

229

229

MedCity News

APRIL 18, 2023

Epic is welcoming generative AI’s entrance into healthcare. The company is expanding its existing collaboration with Microsoft by integrating OpenAI services, such as GPT-4, into its EHR. The partners have already begun piloting OpenAI services at a few health systems, including UC San Diego Health, UW Health and Stanford Health Care.

Healthcare 111

Healthcare Healthcare 111

MedCity News

APRIL 18, 2023

As telehealth providers navigate the ever-evolving abortion terrain, it is important that they evaluate all avenues for potential exposure and risk.

Biopharma 117

Biopharma 117

Pharmaceutical Technology

APRIL 18, 2023

IntelGenx Corp announced that the US Food and Drug Administration (FDA) has approved the company’s Rizafilm VersaFilm new drug application (NDA) for the treatment of acute migraine. The approval was based on successful results from a bioequivalence study comparing Rizafilm to Merck and Co’s Maxalt-MTL and the European reference Maxalt-Lingua. Rizaport and Maxalt are different formulations of Rizatriptan benzoate.

Food and Drug Administration 98

Food and Drug Administration FDA Food Manufacturing 98

MedCity News

APRIL 18, 2023

Older adults and immunocompromised people may now get a second Covid-19 booster shot, according to amendments to the FDA authorizations of the mRNA vaccines. Further changes will be discussed at an advisory committee meeting planned for June.

FDA 102

FDA Biopharma Pharma 102

Copyright Clearance Center

APRIL 18, 2023

April 18, 2023 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, is hosting a panel discussion on “Reading the Data Compass: The Guiding Role of Metadata in an Increasingly Complex Scholarly Research Ecosystem” during the Research & Scholarly Publishing Forum at The London Book Fair on 20 April, 11:40 -12:10 in the Olympia Theatre.

Government 98

Government Media Management Leads 98

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

MedCity News

APRIL 18, 2023

In a recent interview, Dr. Jesse Ehrenfeld, the president-elect at the American Medical Association, outlined how the major pain point of physicians has gone from the EHR to prior authorizations requests. But none of the individual efforts that payers are making is enough.

Physicians 99

Physicians Medical Electronics 99

PM360

APRIL 18, 2023

ISPOR—The Professional Society for Health Economics and Outcomes Research announced the plenary sessions and speakers for its annual international conference, ISPOR 2023. The conference is scheduled for May 7-10 in Boston, MA, USA with the theme, “Impacting Innovation, Value, and Healthcare Decision Making.” Plenary sessions for ISPOR 2023 include the following with speakers added to the online program as they are confirmed: Plenary 1: Global Focus on Affordability and Inward Investment – What

Electronics 97

Electronics Healthcare Healthcare Healthcare Provider 97

MedCity News

APRIL 18, 2023

The American Hospital Association reports that since 2000, hospitals of all types have provided about $745 billion in uncompensated patient care. The goal is to get healthcare providers out of the banking business and shift the financial relationship to third-party financial service providers who take over the payment process for all.

Healthcare 97

Healthcare Healthcare Healthcare Provider Patients 97

PM360

APRIL 18, 2023

ISPOR—The Professional Society for Health Economics and Outcomes Research announced its ISPOR Real-World Evidence Summit 2023 scheduled for May 7 in Boston, MA, USA. The Summit is collocated with and being held immediately prior to the Society’s annual international conference, ISPOR 2023. The Summit is a collaboration between ISPOR, the International Society for Pharmacoepidemiology (ISPE), and the Duke-Margolis Center for Health Policy.

Food and Drug Administration 96

Food and Drug Administration Healthcare Healthcare Food 96

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

PharmaVoice

APRIL 18, 2023

How an “international” childhood sent Dr. José Trevejo, Tarsus’s chief medical officer, on a mission to fight infectious diseases.

Leads 98

Leads Medical 98

Spotio

APRIL 18, 2023

Sales and operations planning, often abbreviated to S&OP, is the cross-functional process of assessing customer buying habits to ensure a company is able to meet the forecasted production, distribution, and purchasing demands required of it. S&OP is typically conducted by executive-level management professionals on a monthly basis and allows them to better align their plans with company-wide objectives.

Sales 90

Sales Management Leads Sales Strategy 90

MedCity News

APRIL 18, 2023

Acquiring Bellus Health gives GSK a drug for recurrent chronic cough that could offer a better side effect profile compared to a Merck drug that addresses the same target. Bayer was also pursuing the target, but stopped work on its drug candidate last year.

Side effects 90

Side effects Biopharma Pharma 90

European Pharmaceutical Review

APRIL 18, 2023

GSK has agreed to acquire late-stage biopharma BELLUS Health, for a total of £1.6 billion. The proposed acquisition will give GSK access to camlipixant, a highly selective P2X3 antagonist for first-line treatment of adults with refractory chronic cough (RCC). “This proposed acquisition builds on our expertise in respiratory therapies,” commented Luke Miels, Chief Commercial Officer at GSK.

Biopharma 83

Biopharma Sales Patients Medical 83

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

MedCity News

APRIL 18, 2023

Artificial Intelligence shows great potential for behavioral healthcare, but it has a ways to go, said Taft Parsons III, vice president and chief psychiatric officer of CVS Health. He made these comments Tuesday at the HIMSS 2023 conference in Chicago.

Healthcare 89

Healthcare Healthcare 89

Medgadget

APRIL 18, 2023

Researchers at the University of Washington have developed GlucoScreen, a smartphone system that can accurately measure blood glucose levels. The technology consists of a test strip onto which a user places a drop of blood. Following an electrochemical reaction on the strip, the data are transmitted to the smartphone through a series of taps on the touch screen, somewhat like Morse code.

Physicians 80

Physicians Medicine 80

MedReps

APRIL 18, 2023

Let’s be honest – practically everyone wants to advance their careers. Staying in the same position for too long can get boring, especially when you watch everyone around you move up the proverbial corporate ladder. However, the methods of advancement aren’t the same for everyone. For example, if you’re a current pharmaceutical sales representative and want to advance your career, how do you do so?

Pharmaceutical Sales 73

Pharmaceutical Sales Sales Pharmaceutical Medical sales 73

MedCity News

APRIL 18, 2023

Anita Nelsen, Senior Vice President of Clinical Trial Operations at Allucent, shares her insights on how to navigate the drug development landscape.

Biopharma 80

Biopharma 80

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization

Copyright Clearance Center

APRIL 18, 2023

The post Uncovering Novel Insights with Data Analytics appeared first on Copyright Clearance Center.

98

98

Fierce Pharma

APRIL 18, 2023

J&J's unstoppable profit engine sputters after $6.

Engineering 100

Engineering 100

PharmaTimes

APRIL 18, 2023

Drug discovery platform is a tool specifically designed for gene-to-function studies using human macrophages

83

83

Pharmaceutical Technology

APRIL 18, 2023

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence. In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: HIV peptides.

Pharmaceutical 59

Pharmaceutical Leads Medical Medicine 59

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

PharmaTimes

APRIL 18, 2023

Collaboration will further boost its promising pipeline of cancer treating therapies

80

80

Evolve Your Success

APRIL 18, 2023

A medical device sales representative can firsthand the impact that innovative technology can have on improving patient outcomes. But having a nursing background is even better as it can be leveraged to making connections with healthcare professionals on deeper levels, and more. In this episode, Samuel Adeyinka interviews Bradley Sadri on his transition from operating room nurse to medical device sales rep.

Medical 52

Medical Sales Medical sales Medical sales reps 52

Pharmaceutical Technology

APRIL 18, 2023

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence. In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Glycoside hydrolase-ba

Pharmaceutical 52

Pharmaceutical Leads Biopharma Manufacturing 52

PharmaTech

APRIL 18, 2023

Moderna and Merck reported that a combination therapy involving pembrolizumab and an mRNA demonstrated a 44% reduction in recurrence or death in cancer patients compared to non-combination treatments.

Patients 52

Patients 52

Advertisement

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

Management